These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33775056)

  • 1. [ACTG2 associated visceral myopathy with intestinal pseudoobstruction].
    Shen MX; Zhao C; Wang YJ; Xin XW; Yin Y; Jin YP
    Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):331-333. PubMed ID: 33775056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACTG2-Associated Visceral Myopathy With Chronic Intestinal Pseudoobstruction, Intestinal Malrotation, Hypertrophic Pyloric Stenosis, Choledochal Cyst, and a Novel Missense Mutation.
    Collins RRJ; Barth B; Megison S; Pfeifer CM; Rice LM; Harris S; Timmons CF; Rakheja D
    Int J Surg Pathol; 2019 Feb; 27(1):77-83. PubMed ID: 30019982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.
    Ravenscroft G; Pannell S; O'Grady G; Ong R; Ee HC; Faiz F; Marns L; Goel H; Kumarasinghe P; Sollis E; Sivadorai P; Wilson M; Magoffin A; Nightingale S; Freckmann ML; Kirk EP; Sachdev R; Lemberg DA; Delatycki MB; Kamm MA; Basnayake C; Lamont PJ; Amor DJ; Jones K; Schilperoort J; Davis MR; Laing NG
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13371. PubMed ID: 29781137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel ACTG2 variants disclose allelic heterogeneity and bi-allelic inheritance in pediatric chronic intestinal pseudo-obstruction.
    Matera I; Bordo D; Di Duca M; Lerone M; Santamaria G; Pongiglione M; Lezo A; Diamanti A; Spagnuolo MI; Pini Prato A; Alberti D; Mattioli G; Gandullia P; Ceccherini I
    Clin Genet; 2021 Mar; 99(3):430-436. PubMed ID: 33294969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segregation of a missense variant in enteric smooth muscle actin γ-2 with autosomal dominant familial visceral myopathy.
    Lehtonen HJ; Sipponen T; Tojkander S; Karikoski R; Järvinen H; Laing NG; Lappalainen P; Aaltonen LA; Tuupanen S
    Gastroenterology; 2012 Dec; 143(6):1482-1491.e3. PubMed ID: 22960657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal Pathology in Patients With Pathogenic
    Kapur RP; Goldstein AM; Loeff DS; Myers CT; Paschal CR
    Pediatr Dev Pathol; 2022; 25(6):581-597. PubMed ID: 35695198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent ACTG2 gene variation in African degenerative visceral leiomyopathy.
    Maluleke T; Mangray H; Arnold M; Moore HA; Moore SW
    Pediatr Surg Int; 2019 Apr; 35(4):439-442. PubMed ID: 30430282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Pyridostigmine-responsive Visceral Myopathy With ACTG2 Mutations: A Case Series.
    Lee H; Park S; Oh JT; Kim HM; Kim S; Lee JS
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):e16-e17. PubMed ID: 30334933
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenotypic expansion of visceral myopathy associated with ACTG2 tandem base substitution.
    Klar J; Raykova D; Gustafson E; Tóthová I; Ameur A; Wanders A; Dahl N
    Eur J Hum Genet; 2015 Dec; 23(12):1679-83. PubMed ID: 25782675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.
    Moreno CA; Metze K; Lomazi EA; Bertola DR; Barbosa RH; Cosentino V; Sobreira N; Cavalcanti DP
    Am J Med Genet A; 2016 Nov; 170(11):2965-2974. PubMed ID: 27481187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the genotypic spectrum of
    James KN; Lau M; Shayan K; Lenberg J; Mardach R; Ignacio R; Halbach J; Choi L; Kumar S; Ellsworth KA
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 33883208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial visceral myopathy diagnosed by exome sequencing of a patient with chronic intestinal pseudo-obstruction.
    Holla OL; Bock G; Busk OL; Isfoss BL
    Endoscopy; 2014 Jun; 46(6):533-7. PubMed ID: 24777424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.
    Matera I; Rusmini M; Guo Y; Lerone M; Li J; Zhang J; Di Duca M; Nozza P; Mosconi M; Pini Prato A; Martucciello G; Barabino A; Morandi F; De Giorgio R; Stanghellini V; Ravazzolo R; Devoto M; Hakonarson H; Ceccherini I
    Eur J Hum Genet; 2016 Aug; 24(8):1211-5. PubMed ID: 26813947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral myopathy diagnosed by a de novo
    Xiong X; Li J; Liu C; Xu F
    Transl Pediatr; 2021 Mar; 10(3):679-685. PubMed ID: 33880338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic intestinal pseudoobstruction and ophthalmoplegia in a patient with mitochondrial myopathy.
    Cervera R; Bruix J; Bayes A; Blesa R; Illa I; Coll J; Garcia-Puges AM
    Gut; 1988 Apr; 29(4):544-7. PubMed ID: 3371723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic intestinal pseudoobstruction: report of four pediatric patients.
    Dalgiç B; Sari S; Doğan I; Unal S
    Turk J Gastroenterol; 2005 Jun; 16(2):93-7. PubMed ID: 16252200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral myopathy causing chronic intestinal pseudoobstruction and intestinal failure in a child with Sanjad-Sakati syndrome.
    Pal K; Moammar H; Mitra DK
    J Pediatr Surg; 2010 Feb; 45(2):430-4. PubMed ID: 20152369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient's dermal fibroblasts as disease markers for visceral myopathy.
    Viti F; Pramotton FM; Martufi M; Magrassi R; Pedemonte N; Nizzari M; Zanacchi FC; De Michele B; Alampi M; Zambito M; Santamaria G; Bajetto A; Sardar S; Tomati V; Gandullia P; Giampietro C; Florio T; Beltrame F; Vassalli M; Ceccherini I
    Biomater Adv; 2023 May; 148():213355. PubMed ID: 36893487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of chronic intestinal pseudo-obstruction and paternal somatic mosaicism for the ACTG2 pathogenic variant.
    Milunsky A; Lazier J; Baldwin C; Young C; Primack D; Milunsky JM
    Prenat Diagn; 2017 Dec; 37(12):1254-1256. PubMed ID: 29072330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intestinal pseudo-obstruction due to sporadic visceral myopathy].
    Montalvo P; Paz L; Chiappa E; Aronne S; Novelli M; Biaiñ ME
    Medicina (B Aires); 2004; 64(6):525-8. PubMed ID: 15637831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.